Moderately to Severely Active Ulcerative Colitis
6 clinical trials · Condition
◉ Watch Moderately to Severely Active Ulcerative Colitis
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis (NCT04176588) | Everstar Therapeutics Limited | 2019-09-10 |
| Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis (NCT03221036) | Takeda | 2017-08-03 |
Track Moderately to Severely Active Ulcerative Colitis automatically
Every clearance here is in the API, with alerts when new ones post.